Literature DB >> 8768851

Hyperinsulinemia is related to erythrocyte phospholipid composition and membrane fluidity changes in obese nondiabetic women.

H Candiloros1, N Zeghari, O Ziegler, M Donner, P Drouin.   

Abstract

It has been suggested that changes in the properties of cell membranes are involved in an altered insulin action. However, the influence of changes in the distribution of phospholipid classes has not been explored. We investigated 69 obese nondiabetic normoglycemic women (17 patients with impaired glucose tolerance) with varying degrees of insulin sensitivity to determine the phospholipid composition and fluid state of their erythrocyte plasma membranes. The fasting plasma insulin, the homeostasis model analysis of insulin resistance (HOMA), and the integrated area under the insulin curve (AUC-I) after an oral glucose challenge were used as markers of insulin resistance. Results were divided into normal glucose tolerance (NGT) and impaired glucose tolerance. There was a positive correlation in NGT group between the membrane sphingomyelin (SM) content and the fasting plasma insulin (r = 0.523; P < 0.0001), HOMA value (r = 0.483; P < 0.0005), and AUC-I (r = 0.352; P < 0.05) and negative correlations between membrane fluidity determined with two fluorescent probes and plasma fasting insulin (r = 0.320; r = -0.365; P < 0.05) and HOMA value (r = 0.321; r = -0.382; P < 0.05). There were also correlations between SM and the three markers of insulin resistance in the impaired glucose tolerance group. There was no correlation between insulin resistance and other membrane components. Stepwise multiple regression analysis in the NGT group confirmed that the membrane SM content was an independent predictor of plasma fasting insulin, HOMA values, and AUC-I variations. Sphingomyelin could be one of the membrane parameters contributing to insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8768851     DOI: 10.1210/jcem.81.8.8768851

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  "Actin"g on GLUT4: membrane & cytoskeletal components of insulin action.

Authors:  Joseph T Brozinick; Bradley A Berkemeier; Jeffrey S Elmendorf
Journal:  Curr Diabetes Rev       Date:  2007-05

Review 2.  Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein-coupled receptor structure and function.

Authors:  Aditya J Desai; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

3.  Loss of cortical actin filaments in insulin-resistant skeletal muscle cells impairs GLUT4 vesicle trafficking and glucose transport.

Authors:  Alicia M McCarthy; Kristen O Spisak; Joseph T Brozinick; Jeffrey S Elmendorf
Journal:  Am J Physiol Cell Physiol       Date:  2006-06-14       Impact factor: 4.249

4.  Evidence coupling increased hexosamine biosynthesis pathway activity to membrane cholesterol toxicity and cortical filamentous actin derangement contributing to cellular insulin resistance.

Authors:  Padma Bhonagiri; Guruprasad R Pattar; Kirk M Habegger; Alicia M McCarthy; Lixuan Tackett; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2011-06-28       Impact factor: 4.736

Review 5.  Signaling, cytoskeletal and membrane mechanisms regulating GLUT4 exocytosis.

Authors:  Nolan J Hoffman; Jeffrey S Elmendorf
Journal:  Trends Endocrinol Metab       Date:  2011-01-07       Impact factor: 12.015

6.  Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin.

Authors:  Padma Bhonagiri; Guruprasad R Pattar; Emily M Horvath; Kirk M Habegger; Alicia M McCarthy; Jeffrey S Elmendorf
Journal:  Endocrinology       Date:  2008-11-26       Impact factor: 4.736

Review 7.  Sphingolipids in obesity, type 2 diabetes, and metabolic disease.

Authors:  S B Russo; J S Ross; L A Cowart
Journal:  Handb Exp Pharmacol       Date:  2013

8.  Biomarker profiling of postmortem blood for diabetes mellitus and discussion of possible applications of metabolomics for forensic casework.

Authors:  Maika Nariai; Hiroko Abe; Yumi Hoshioka; Yohsuke Makino; Hirotaro Iwase
Journal:  Int J Legal Med       Date:  2022-01-20       Impact factor: 2.686

9.  Metabolomic and Lipidomic Analysis of Serum Samples following Curcuma longa Extract Supplementation in High-Fructose and Saturated Fat Fed Rats.

Authors:  Fabrice Tranchida; Laetitia Shintu; Zo Rakotoniaina; Léopold Tchiakpe; Valérie Deyris; Abel Hiol; Stefano Caldarelli
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.